Current Portfolio
Shinobi Therapeutics
Shinobi Therapeutics is a biotechnology company developing a new class of off-the-shelf immune evasive iPSC-derived cell therapies.
Key Facts
- Sector
Life Sciences
- Country
United States
- Fund
LSP 7
- Entry
2023
Website
Do You Want to Know More?
We are eager to explore how we can achieve great things together.